Top Markets
Coin of the day
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Classement en actions #41072
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Prix de l'action
$0.0005
Dernière synchronisation: 2026-08-12
Capitalisation boursière
$16.62K
Changement (1 jour)
-64.29%
Changement (1 an)
400.00%
Pays
US
Échange WayPoint Biomedical Holdings, Inc. (WYPH)

Catégorie

EPS pour WayPoint Biomedical Holdings, Inc. (WYPH)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de WayPoint Biomedical Holdings, Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de WayPoint Biomedical Holdings, Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$4.97 -
US
- -
CA
$1.62 -
US
$0.68 -
AU
$2.35 -
US